Pancreatic Cancer Research

ResearcherNational Institutes of HealthNo recent work listed

Jeremy L. Davis

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6334-6936; OpenAlex author ID A5066867006. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers

Papers 4

  1. Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-19-3624↗
  2. Targeting CA 19-9 with a humanized monoclonal antibody at the time of surgery may decrease recurrence rates for patients undergoing resections for pancreatic c… Co-author DOI 10.21037/jgo.2020.02.01↗
  3. Expanding surgical treatment of pancreatic cancer: the role of regional chemotherapy. Co-author DOI 10.1097/mpa.0b013e318249955a↗
  4. Regional chemotherapy in locally advanced pancreatic cancer: RECLAP trial. Co-author DOI 10.1186/1745-6215-12-129↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jonathan Matthew Hernandez · 2 shared papers, 2020 · strength 0.20
  2. Shreya Gupta · 1 shared paper, 2020 · strength 0.11
  3. Freddy E. Escorcia · 1 shared paper, 2020 · strength 0.09
  4. Tim F. Greten · 1 shared paper, 2020 · strength 0.09
  5. Changqing Xie · 1 shared paper, 2020 · strength 0.09
  6. Austin G. Duffy · 1 shared paper, 2020 · strength 0.09
  7. Itzhak Avital · 2 shared papers, 2011–2012 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.